Table 5.
Variable | Patients without HCC C(= 7) | = 7)Pats with HCC ients with HCC = 36) | p |
---|---|---|---|
= 36)pBMI (kg/m2n (Q1-Q3) | , medi28.0-33.5) | 29.0 (27.8-32.2) | n (Q2 |
1-Q3)29.0 (28.0-33.5)29.0 (27.8-32.2)0.691-Q3) | 2Age (ye) | 59.0 (57.0-65.2) | rs947 |
), median (Q1-Q3women | 2 (28.6) | 59.0 (58) | 1.5-0 |
70.0)59.0 (57.0-65.2)0.947Sex, n (Q1-Q3) | (%) of wome) | 0.4 (0.2-0.6) | 2 (20 |
8.6)10 (27.8)1.00SD | 0.5 | aspin (ng/ml9 | 0.870 |
, median (Q1-Q3)0.1 (0.1-0.2)0.4 (0.2) | -0.6(2.0-2.9) | )0.09.5) | 0.669 |
Visfatin (ng/ml), mean ±SD4.4 ±-Q3) | 25.0 (22.7-43.6) | .6.5 (24.1-48.6) | 0.733 |
4.3 ±1.90.870Irisin () | μg/ml6) | ), median ) | (Q1-2 |
Q3)2.1 (2.0-2.9)2.3 (1.7-) | 3.528.6%) | 12 (33.3%) | 0.669Bet0 |
atrophin (ng/ml), m) | edi14.3%) | 12 (33.3%) | n (Q9 |
1-Q3)25.0 (22.7-43.6)36.5 (24.1-48.6)0.731-Q3) | 58.0 (36.0-86.5) | Insulin (ng/ml2) | 0.818 |
, median (Q1-Q3)0.7 (0.4) | -8.0 (56.5- 99.5) | 1.6-139.5) | 0.831 |
1.0 (0.5-1.3±SD | 119.7 ±97.0 | 0.478 ±80.8 | 0.524 |
Type 2 diabetes, n (Q1-Q3) | (%0 (37.5-122.0) | 95.5 (64.2-170.8) | 2 (23 |
8.6%)12 (33.3%)1.00Q1-Q3) | 85.1 (77.2-140.7) | Hypertensio2-179.5) | 0.023 |
, n(%)1 (14.3%) | 77.0 (49.0-120.9) | 12 (33.3%.9-133.0) | 0.300 |
0.579ALT (IU/l), mediQ3) | 39.7 (32.6-47.6) | n (Q1-Q3.2-45.2) | 0.543 |
58.0 (36.0-86.5)60.0 (40.0-91.2±SD | 69.4 ±15.1 | 0.81 ±13.8 | 0.402 |
AST (IU/l), median (Q1-Q3)68.0 (56.5- 99.5)96.5 (51 | .8-139.8 | 5)01 | .8396 |
1ALP (IU/l), mean ±SD | 3.3 ±0.5 | 119.7 ±5 | 97.53 |
0145.8 ±80.80.524GGTP (IU) | /l7 (4.4-14.9) | 42.1 (15.0-188.4) | , me5 |
dian (Q1-Q3)50.0 (37.5-122.0)95.5 (64) | .2-170.8-7.3) | 3.1 (2.2-4.6) | 0.189 |
3TChol (mg/ml (Q1-Q3) | 10.6 (6.2-32.7) | , medi6.9-25.3) | 0.717 |
BMI – body mass index, ALT – alanine aminotransferase, AST – aspartate aminotransferase, WBC – white blood cell count, HGB – hemoglobin, ALT – alanine transferase, AST – aspartate transferase, ALP – alkaline phosphatase, GGTP – gamma glutamyl transpeptidase, TChol – total cholesterol, TG – triglycerides, HDL – high-density lipoprotein, PT – prothrombin time, AFP – α-fetoprotein, CEA – carcinoembryonic antigen, CA – cancer antigen